Importancia diagnóstica de los anticuerpos antinucleares
Keywords:
anticuerpos antinucleares, enfermedades autoinmunes del tejido conjuntivo, inmunofluorescencia IndirectaAbstract
Los anticuerpos antinucleares se presentan en el suero de pacientes con enfermedades de origen reumáticas, como el lupus eritematoso sistémico, síndrome de Sjögren, esclerosis sistémica progresiva y polimiositis. En 1948, descubrieron la célula lupus eritematoso y su relación con el lupus eritematoso sistémico, señalando el carácter autoinmune de la enfermedad, al demostrar la existencia de unas sustancias que la llamarían autoanticuerpos. Las pruebas de los anticuerpos antinucleares son muy útiles en el estudio de las enfermedades autoinmunes del tejido conjuntivo. Cada una de ellas dispone de una colección particular de anticuerpos que ayuda, en unos casos, a poder establecer el diagnóstico y, en otros, además, a señalar el pronóstico de la enfermedad.Downloads
References
Fernández-Madrid F, Mattioli M. Anti-nuclear antibodies (ANA): immunologic and clinical significance. Semin Arthur Rheum.1976; VI: 83-124.
Fong KY, Boey ML, Howe HS, Feng PH. Antinuclear antibodies in systemic lupus erythematosus. Med J Malaysia. 1989;44:151-5.
Smeenk RJT, van der Brink HG, Brinkman K, Termaat RM, Berden JHM, Swaak AJG. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int .1991; 11:101-7.
Sontheimer RD, McCauliffe DP,Zappi E, Targoff I. Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol.1991; 7: 3-52.
Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in ‘healthy’ individuals. Arthr Rheum.1997; 40: 1601-1611.
Emlen W, O’Neill L. Clinical significance of antinuclear antibodies; comparison of detection with immunofluorescence and enzyme-linked immu-nosorbent assays. Arthr Rheum.2007; 40: 1612-1618.
Ward MM. Laboratory testing for systemic rheumatic diseases. Postgrad Med. 2008; 103: 93-100.
Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child. 1997; 77: 299-304.
Evans J. Antinuclear antibody testing in systemic autoimmune disease.Clin Chest Med.1998; 19: 613-625.
Provost TT, Watson R, Simmons-O’Brien E. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol.1996; 35: 147-169.
Xavier RM, Yamauchi Y, Nakamura M, et al. Antinuclear antibodies in healthy aging people: a prospective study.Mech Ageing Dev. 1995; 78: 145-154.
Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol .2007; 19:636-43.
Minoru Satoh. Mónica Vázquez - Del Mercado. Edward K. L. Chan Mod Rheumatol. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases.2009; 19:219-228.
Stinton LM, Fritzler MJ. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoinmun Rev 2007; 7:77-84.
Lee SJ, Kavanaugh A. Autoimmunity, vasculitis, and autoantibodies. J Allergy Clin Immunol 2006; 117:S445-50.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
